Home » Consulting Services » Business and Data Analysis »

Business and Data Analysis

Business and Data Analysis

PHSL uses its vast industry experience along with analysis techniques and financial modeling to solve your toughest business problems. We analyze your situation from different points of view and identify opportunities or potential problems before they occur. Prior to your investment in a new business process or program, let PHSL model and assess its impact on your financial results.

View our case studies related to business and data analysis:

340B Compliance Review

Accounting Firm Required Pharmacy Expertise

Assessment of Specialty Generics Contract with PBM

Client Selects Copay Reduction Program

Comparing Product Financial Impacts Across Stakeholders

Determining Competitive Market Landscape

Drug Resources Made Available via Manufacturer’s Website

Generic Competition Studied to Determine Effects on Brand Drug

Generic Market Forecasting

Health Systems Seeks Insight on Increasing Biosimilar Adoption Rate

Industry Monitoring, Research, & Analysis Used as a Vital Decision Resource

Manufacturer Seeks Pre-Launch Rebate Level Forecasting

Medicare PDP Develops Community Pharmacy MTM Program

PBM Contract Variance Analysis

PBM Positions Itself for Increased Rebate Yield

PHSI Helps PBM Develop a Pharmacy Network Contracting Strategy

PHSI Helps Supermarket Chain Move Toward Providing Pharmaceutical Care

PHSL Analyzes Data to Save Retail Pharmacy in Drug Costs

Proactive Response to Loss of Brand Patent Protection

Rebate Contracting Consolidation Process Directed by PHSI

Research Updates Brand Designation in Drug Databases

Seasonal-Use Product Reimbursement Trend Analysis

Specialty Drug Reimbursement by Pharmacy Type

Stakeholder Financial Perspectives for Brand Product Reimbursement

U&C Pricing Strategy Critical for Chain Expansion

Validation of Pharmacy Payment Methodology versus NADAC

June 2021 Question of the Month

If COVID vaccination in children less than 12 years old is authorized this fall, will you vaccinate your children?

Yes: 18%

No: 59%

Undecided: 24%

May 2021 Question of the Month

How do you expect the new Pharmacist job market to look in the coming year?

More competitive: 71%

Less competitive: 6%

Same / no change: 24%

April 2021 Question of the Month

Is the pharmacy industry overall ready for the transition to UDI by the deadline?

All affected segments of the industry will be ready: 0.0%

Many segments of the industry will be ready with challenges: 0.0%

Old and new identifiers found in the marketplace for the same device will create confusion: 0.0%

Submitting claims for devices will be difficult during the transition:66.7%

Reimbursement payments for devices will be adversely affected: 0.0%

Many segments will not be ready making it difficult to dispense devices: 33.3%

I don’t have insight on this issue: 0.0%